Wellness Resources
Vaccines that use human fetal cells draw fire
Senior Catholic leaders in the United States and Canada, along with other antiabortion groups, are raising ethical objections to promising...
View detailsWellness Resources News
Science-based natural health news to help you take charge of your health!
Wellness Resources
Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study).
Background: BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have been rapidly rolled out in the UK. We determined the...
View detailsWellness Resources
Assessing the Effectiveness of BNT162b2 and ChAdOx1nCoV-19 COVID-19 Vaccination in Prevention of Hospitalisations in Elderly and Frail Adults: A Single Centre Test Negative Case-Control Study.
Background: On 8th December 2020, deployment of the first vaccine against SARS-CoV-2 authorised for UK use, the mRNA-based vaccine BNT162b2,...
View detailsWellness Resources
Vaccine after Effects and Post-Vaccine Infection in a Real World Setting: Results from the COVID Symptom Study
Background: The Pfizer-BioNTech (BNT162b2) and the Oxford/AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in Phase III...
View detailsWellness Resources
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with...
View detailsWellness Resources
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.
At the moment, scientists are frantically trying to develop either a definitive cure, neutralizing antibodies, or a vaccine to protect...
View detailsWellness Resources
Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.
AbstractSince the early 1800s vaccines have saved numerous lives by preventing lethal infections. However, during the past two decades, there...
View detailsWellness Resources
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
Background: Testing of vaccine candidates to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older population...
View detailsWellness Resources
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of...
View details